L. Kuhn et al., Interferon-gamma and interleukin-10 production among HIV-1-Infected and uninfected infants of HIV-1-infected mothers, PEDIAT RES, 50(3), 2001, pp. 412-416
Immunologic consequences of exposure to HIV-1 in utero are still poorly und
erstood. This study investigates relationships between type-l [interferon-g
amma (IFN-gamma)] and type-2 (IL-10) cytokine production and maternal-infan
t HIV-1 transmission. Cord blood leukocytes from deliveries of 71 HIV-1-inf
ected and 11 uninfected mothers were tested for in vitro IFN-gamma and IL-1
0 production after phytohemagglutinin (PHA) stimulation. The infants of the
se HIV-1-infected mothers were followed prospectively after birth to determ
ine HIV vertical transmission, and IFN-gamma and IL-10 production was measu
red again at 6 mo. Median PHA-stimulated IFN-gamma production was 210 pg/mL
in cord blood cells from infected and 73 pg/mL from uninfected mothers (p
= 0.12), and median PHA-stimulated IL-10 production was 491 pg/mL in cord b
lood cells from infected and 161 pg/mL from uninfected mothers (p = 0.004).
PHA-stimulated IFN-gamma and IL-10 production alone were not significantly
associated with transmission, but relationships between the two cytokines
differed among infected and uninfected infants of HIV-1-infected mothers. P
RA-stimulated IFN-gamma and IL-10 production was positively correlated amon
g infected (r = 0.7, p = 0.12 in cord blood and r = 0.66, p = 0.03 at 6 mo)
but not uninfected infants, and stronger relative production of IFN-gamma
to IL-10 was observed among exposed uninfected than among infected infants
(p = 0.04). Exposure in utero to HIV-1 may augment production of IL-10 dete
ctable in fetal cord blood. Stronger relative production of IFN-gamma to IL
-10 in cord blood cells from infants of HIV-1-infected mothers may be assoc
iated with protection against perinatal HIV infection.